James Brumley

James Brumley

InvestorPlace Feature Writer

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Before Laughing at Einhorn’s Taco Bell/Chipotle Theory …

By James Brumley, InvestorPlace Feature Writer

David Einhorn's statement about Taco Bell threatening Chipotle stock has been met with some laughs, but some big-picture numbers aren't as funny.

Tim Cook’s Unapologetic Maps Apology Is Oddly Familiar

By James Brumley, InvestorPlace Feature Writer

Tim Cook's response to the Apple Maps snafu is peppered with some trademark smarm we're used to from Cupertino's C-Suite.

Will Global Hyperstimulation Hit the Target?

By James Brumley, InvestorPlace Feature Writer

The hundreds of billions of dollars that governments are throwing at their economic woes should get the wheels spinning -- but will it keep them spinning?

Lovable Brands, Detestable Stocks

By James Brumley, InvestorPlace Feature Writer

Million-dollar ideas don't necessarily turn into money-minting stocks. These six product or business models may be cool, but they need to be profitable.

Bank of America Is Missing the Point

By James Brumley, InvestorPlace Feature Writer

Bank of America clearly has forgotten that you can't shrink your way to greatness. In fact, BAC might be shrinking its way to more problems.

Another Big Price Target for Gold? Yawn.

By James Brumley, InvestorPlace Feature Writer

Does Merrill Lynch analysts' $2,400 gold target have any chance of standing up? And do we need all these crap predictions in the first place?

China Isn’t ‘Easy Money’ Anymore

By James Brumley, InvestorPlace Feature Writer

As Starbucks, Best Buy and other companies are starting to prove, there's such a thing as being "too American" to do business there.

Buy Gold Mining Stocks … Just Not THESE Gold Mining Stocks

By James Brumley, InvestorPlace Feature Writer

Some mining operations seem to be perennial disappointments, unable to live up to expectations no matter what the environment -- like, these four.

A $36 Billion Opportunity Big Banks Are Chasing Away

By James Brumley, InvestorPlace Feature Writer

"Unbanked" and "underbanked" Americans still need cash and spending flexibility, and those who are providing that service are doing surprisingly well.

Who Has the Best Pharma Pipeline?

By James Brumley, InvestorPlace Feature Writer

A look through Big Pharma's drug pipelines shows a lot of promise across several companies, but one firm stands out as having big-time revenue growth potential.

Load More